p16 INK4A (F2T7H) Rabbit Monoclonal Antibody and 4 more items

The University of Virginia awarded a contract to Cell Signaling Technology Inc. on August 8, 2026, with a cumulative value of $776. The contract, identified as A207_PO-0446159-V3, involves the procurement of five distinct rabbit monoclonal antibodies for research purposes. These antibodies target specific cellular proteins involved in cell cycle regulation: p16 INK4A, cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 4 (CDK4), p21 Waf1/Cip1, and Cyclin D1. The products are designated for delivery to the University of Virginia as the buyer.

The contract specifies the delivery of 775 units across the five line items, with quantities ranging from 144 to 160 units per antibody type and a standardized unit price of $1 per item. Each antibody is identified by a proprietary catalog designation and is classified as a rabbit monoclonal antibody, indicating their use in laboratory research applications. No explicit period of performance or annual value separate from the cumulative contract amount is documented in the available contract data.